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Abstract Cyanobacteria (83 strains and seven natural
populations) were screened for content of apoptosis (cell
death)-inducing activity towards neoplastic cells of the
immune (jurkat acute T-cell lymphoma) and hematopoetic
(acute myelogenic leukemia) lineage. Apoptogenic activity
was frequent, even in strains cultured for decades, and was
unrelated to whether the cyanobacteria had been collected
from polar, temperate, or tropic environments. The activity
was more abundant in the genera Anabaena and Micro-
cystis compared to Nostoc, Phormidium, Planktothrix, and
Pseudanabaena. Whereas the T-cell lymphoma apoptogens
were frequent in organic extracts, the cell death-inducing
activity towards leukemia cells resided mainly in aqueous
extracts. The cyanobacteria were from a culture collection
established for public health purposes to detect toxic
cyanobacterial blooms, and 54 of them were tested for
toxicity by the mouse bioassay. We found no correlation
between the apoptogenic activity in the cyanobacterial
isolates with their content of microcystin, nor with their
ability to elicit a positive standard mouse bioassay. Several
strains produced more than one apoptogen, differing in
biophysical or biological activity. In fact, two strains
contained microcystin in addition to one apoptogen specific
for the AML cells, and one apoptogen specific for the
T-cell lymphoma. This study shows the potential of
cyanobacterial culture collections as libraries for bioactive
compounds, since strains kept in cultures for decades
produced apoptogens unrelated to the mouse bioassay
detectable bloom-associated toxins.
Keywords Cyanobacteria  Apoptosis  Cell death 
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Introduction
Cyanobacteria inhabit all prevalent terrestrial and aquatic
environments [43] and are a rich source of structurally
diverse bioactive compounds [37]. Cyanobacteria can form
toxic blooms [38], but are also a promising source of
potential anticancer agents [40] and possibly of immuno-
suppressive compounds [27, 31, 44].
The bloom-associated toxins (see [7, 38, 42] for
reviews) attack several organs, depending on the nature of
their cellular target, like the neurotoxic anatoxins,
depending on preferential uptake into particular cells, like
the hepatotoxic microcystins, or primary contact with
specific organs, like the dermatotoxin lyngbyatoxin.
It should be noted that microcystins, if introduced into cells,
are able to induce rapid death of all mammalian cells [12].
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Toxic blooms are also associated with the production of
more general cytotoxins like cylindrospermopsin [18]. The
bloom-associated toxins are commonly detected by the
acute mouse bioassay, which is widely used to monitor
drinking and recreational waters to prevent human and
animal fatalities [6, 7].
Isolation of bioactive compounds from field collections
is problematic, since re-collection of the field sample is
needed if an interesting compound is present in minuscule
amounts. In addition, the true producer of a bioactive
compound can be difficult to identify, since field collec-
tions of cyanobacteria are often an assemblage of multiple
organisms. On the other hand, established cyanobacterial
culture collections constitute a sustainable source of axenic
culturable cyanobacteria and a reliable resource for bio-
active compounds, making such collections important
within research and bioprospecting [9]. Bioactive com-
pounds isolated from cyanobacteria have potential as
pharmaceuticals with diverse applications [3, 19]. So far,
the most promising drug candidates from cyanobacteria are
directed against cancer cells, several cyanobacterial com-
pounds or derivatives thereof being in clinical or preclini-
cal trials against solid cancers [30, 35].
The present study was undertaken to obtain an overview
of the apoptosis-inducing activity against T-cell lymphoma
and acute myelogenic leukemia (AML) cells in cultured
cyanobacteria, especially in relation to other bioactivities
(e.g., mouse toxicity and protein phosphatase inhibition).
In addition to providing information about the effect of
long-term culturing and the frequency of apoptogens in
cyanobacteria from diverse climates, habitats, and genera,
the study shows the potential of cyanobacterial culture
collections as a resource for immunosuppressive and anti-
leukemic drugs.
Materials and methods
Laboratory cultures and field samples
The cyanobacterial strains used in the investigation
(Table 1A) are maintained in the NIVA Culture Collec-
tion of Algae [9]. The classification and nomenclature of
the relevant strains are according to the prevailing
taxonomic systems [4, 22, 23]. The strains were grown in
1.5 l Z8 medium [24] at 20C on a shaking table that was
illuminated by fluorescent lamps (Philips Tl 65 W/33) at
an intensity of 60 lmol photons m-2 s-1. Cyanobacterial
biomass was harvested by centrifugation at 8,000 9 g
for 10 min, lyophilized, and kept at -80C until extrac-
tion. Larger-scale production was in vertical tubular
photobioreactors with injection of compressed air-CO2
mixture. Biomasses from natural cyanobacterial popula-
tions in seven selected inland lakes were collected during
bloom conditions. The material represents species from
five genera (Table 1B).
Mouse bioassay
Female mice (Bom:NMRI) weighing 15–25 g were fed
ad libitum on standard chow and treated in accordance with
Norwegian law and FELASA guidelines. For toxicity
testing, 50 mg of lyophilized cyanobacterial biomass was
suspended in 1 ml of sterile 0.9% NaCl solution and
injected intraperitoneally. Routinely, each extract was
tested on two mice. Symptoms were observed and regis-
tered during the following 48 h. Hepatotoxicity and
neurotoxicity were judged as previously described [1, 39].
Extraction of cyanobacterial biomass
Extraction of cyanobacterial biomass for analytical purposes
was performed as described [17]. Briefly, 20 mg of freeze-
dried cyanobacterial biomass was extracted sequentially in
water (A extract), 70% aqueous methanol (B extract), and 1/1
(v/v) methanol:dichloromethane (C extract). The extracts
were dried in a centrifugal vacuum concentrator and resus-
pended in 0.2 ml of water (A and B extract) or in 0.05/0.15
(v/v) ml of DMSO/water (C extract).
Cell culturing and experimental conditions
IPC-81 rat promyelocytic leukemia suspension cells [25]
were cultured in Dulbecco’s modified Eagle’s medium
(EuroClone Life Sciences Division, Milan, Italy) with
10% (v/v) heat-inactivated horse serum (EuroClone Life
Sciences Division, Milan, Italy). Jurkat human T-cell
lymphoma suspension cells (American Type Culture Col-
lection, Rockville, MD, US) were cultured in RPMI 1640
medium (Gibcoinvitrogen cell culture, Invitrogen AS,
Carlsbad, CA, USA) with 10% (v/v) heat-inactivated fetal
calf serum (EuroClone Life Sciences Division, Milan,
Italy). Culturing density was between 1 9 105 and
8 9 105 cells/ml and adjusted by dilution in fresh medium
every 2–3 days. Cells were incubated at 37C in a humid
atmosphere with 5% CO2.
The cells were seeded in 96-well tissue culture plates
(0.1 ml cell suspension/well, 1.5 9 105 cells/ml) and incu-
bated with cyanobacterial extracts or vehicle for 18 h, when
the cells were fixed (1:1) in 2% buffered formaldehyde (pH
7.4) containing 0.01 mg/ml of the DNA specific fluorescent
dye Hoechst 33342 (Sigma-Aldrich, St. Louis, MO, USA).
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Table 1 Origin and mouse toxicity of the cyanobacterial material screened
A. Cyanobacterial strains from the NIVA Culture Collection of Algae
Species NIVA strain Isolated Geographical location Biotope Mouse
toxicitya
Order: Chroococcales
Chroococcus sp. CYA 330 1995 Holmestrandfjorden SE. Norway Marine Fjord –
Cyanobium sp. CYA 230 1987 O¨stra Kyrksundet A˚land Eutrophic lake n.d.
Cyanosarcina sp. CYA 386 1996 Plattenberg Bay South Africa Seepage water n.d.
Cyanothece sp. CYA 304 1991 River Atna Mid. Norway Lotic biotope n.d.
Cyanothece aeruginosa CYA 258/2 1990 Queen Maud’s Land Antarctica Gravel, soil n.d
Merismopedia punctata CYA 16 1970 L. Steinsfjord SE. Norway Mesotrophic lake n.d.
Microcystis aeruginosa CYA 57 1978 L. Frøylandsvatn W. Norway Eutrophic lake H
Microcystis aeruginosa CYA 143 1984 L. Akersvatn SE. Norway Eutrophic lake –
Microcystis aeruginosa CYA 160/1 1985 L. Akersvatn SE. Norway Eutrophic lake T
Microcystis aeruginosa CYA 228/1 1987 L. Akersvatn SE. Norway Eutrophic lake H
Microcystis aeruginosa CYA 475 2003 L. Victoria Uganda Eutrophic lake n.d
Microcystis aeruginosa CYA 476 2004 L. Victoria Uganda Eutrophic lake n.d
Microcystis aeruginosa CYA 477 2003 L. Victoria Uganda Eutrophic lake n.d
Microcystis aeruginosa CYA 478 2003 L. Victoria Uganda Eutrophic lake n.d
Microcystis botrys CYA 264 1990 L. Frøylandsvatn W. Norway Eutrophic lake n.d.
Microcystis cf. novacekii CYA 431 2000 L. Victoria Uganda Eutrophic lake n.d.
Microcystis cf. wesenbergii CYA 172/5 1985 L. Arresø Denmark Eutrophic lake n.d.
Microcystis ichthyoblabe CYA 279 1990 L. Østensjøvatn SE. Norway Eutrophic lake –
Microcystis viridis CYA 122/2 1983 L. Finjasjo¨n S. Sweden Eutrophic lake n.d.
Synechococcus sp. CYA 379 1996 Sognefjord W. Norway Marine fjord n.d.
Synechococcus sp. CYA 388 1996 Hadelandstjern SE. Norway Freshwater n.d.
Synechococcus elongatus CYA 187 1985 Queen Maud’s Land Antarctica Detritus n.d.
Synechococcus nidulans CYA 20 \1973 No information T
Order: Nostocales
Anabaena circinalis CYA 82 1980 L. Steinsfjord SE. Norway Mesotrophic lake –
Anabaena flos-aquae CYA 269/6 1990 L. Frøylandsvatn W. Norway Eutrophic lake H
Anabaena lemmermannii CYA 83/1 1980 L. Edlandsvatn W. Norway Mesotrophic lake H
Anabaena lemmermannii CYA 281/1 1990 L. Storavatn W. Norway Oligotrophic lake –
Anabaena lemmermannii CYA 298 1990 L. Storavatn W. Norway Oligotrophic lake –
Anabaena spiroides CYA 358 1996 L. Balaton Hungary Mesotrophic lake T
Anabaena subcylindrica CYA 323 1993 Fuggdalen E. Norway Minerval spring n.d.
Anabaenopsis arnoldii CYA 135/2 1984 L. Turkana Kenya Great Rift Valley Lake –
Aphanizomenon gracile CYA 338 1994 L. Balaton Hungary Mesotrophic lake –
Aphanizomenon cf. klebahnii CYA 372 1996 L. Balaton Hungary Mesotrophic lake n.d.
Cylindrospermopsis raciborskii CYA 225 1984 L. Balaton Hungary Mesotrophic lake T
Cylindrospermopsis raciborskii CYA 399 1997 L. Balaton Hungary Mesotrophic lake T
Cylindrospermum sp. CYA 245 1988 Spydeberg SE. Norway Agricultural soil n.d.
Dichothrix sp. CYA 518 2004 Disko Island Greenland Melt water puddle n.d.
Nodularia cf. harveyana CYA 227 \1986 No information –
Nostoc sp. CYA 124 1983 L. Steinsfjord SE. Norway Mesotrophic lake –
Nostoc sp. CYA 195 1985 Queen Maud’s Land Antarctica Lotic biotope –
Nostoc sp. CYA 295 1990 Ny A˚lesund Spitsbergen Limestone gravel n.d.
Nostoc sp. CYA 308 1990 Ny A˚lesund Spitsbergen Epiphytic on moss T
Nostoc sp. CYA 309 1990 Ny A˚lesund Spitsbergen Epiphytic on moss n.d.
Nostoc sp. CYA 512 2004 Disko Island Greenland Melt water puddle n.d.
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Table 1 continued
A. Cyanobacterial strains from the NIVA Culture Collection of Algae
Species NIVA strain Isolated Geographical location Biotope Mouse
toxicitya
Nostoc sp. CYA 520 2005 Spydeberg SE. Norway Garden pool n.d.
Scytonema sp. CYA 345 1993 Queen Maud’s Land Antarctica Gravel, soil –
Order: Oscillatoriales
Arthrospira sp. CYA 447 n.d. L. Paracas Peru Freshwater (T)
Leptolyngbya foveolarum CYA 54 1975 Spydeberg SE. Norway Air sample –
Limnothrix redekei CYA 106 1982 L. Ma¨laren Sweden Eutrophic lake n.d.
Lyngbya major CYA 173 1987 Kajiki, Kagoshima Japan Garden pond n.d.
Oscillatoria curviceps CYA 149 1984 Bjørndalen Spitsbergen Melt water –
Phormidium breve CYA 76 1956 Dax SW. France Lake n.d.
Phormidium sp. CYA 181 1985 Queen Maud’s Land Antarctica Sandfield T
Phormidium sp. CYA 184 1985 Queen Maud’s Land Antarctica Melt water T
Phormidium sp. CYA 203 1984 Coraholmen Spitsbergen Moraine soil T
Phormidium sp. CYA 210 1985 Grumant Spitsbergen Boggy soil –
Phormidium sp. CYA 315 1993 Lier, Buskerud SE. Norway Greenhouse soil –
Phormidium sp. CYA 448 1990 Eidsvoll SE. Norway Seepage water n.d.
Phormidium sp. CYA 454 2000 Sandebukta SE. Norway Marine fjord n.d.
Phormidium cf. formosum CYA 110 1977 River Saka Japan Lotic biotope n.d.
Phormidium cf. subfuscum CYA177 1985 Queen Maud’s Land Antarctica Gravel, soil T
Phormidium formosum CYA 92 1981 L. Levrasjo¨n S. Sweden Mesotrophic lake N
Planktothrix agardhii CYA 21 1973 Gulf of Finland SE. Finland Brackish water –
Planktothrix agardhii CYA 29 1968 L. Gjersjøen SE. Norway Eutrophic lake H
Planktothrix agardhii CYA 116 1983 L. A˚rungen SE. Norway Eutrophic lake –
Planktothrix agardhii CYA 126 1984 L. La˚ngsjo¨n A˚land Dystrophic lake H
Planktothrix agardhii CYA 127 1984 L. Vesija¨rvi Finland Eutrophic lake n.d.
Planktothrix agardhii CYA 11 1964 L. Akersvatn SE. Norway Eutrophic lake H
Planktothrix rubescens CYA 406 1998 L. Steinsfjord SE. Norway Mesotrophic lake n.d.
Planktothrix rubescens CYA 98 1982 L. Steinsfjord SE. Norway Mesotrophic lake H
Planktothrix rubescens CYA 97/3 1982 L. Steinsfjord SE. Norway Mesotrophic lake H
Planktothrix rubescens CYA 407 1998 L. Steinsfjord SE. Norway Mesotrophic lake n.d.
Prochlorothrix sp. CYA 8/90 1990 L. Ma¨laren E. Sweden Eutrophic lake T
Pseudanabaena sp. CYA 93 1981 L. Gjersjøen SE. Norway Eutrophic lake –
Pseudanabaena sp. CYA 94 1982 River Gla˚ma SE. Norway Lotic biotope –
Pseudanabaena sp. CYA 167 1968 Lough Neagh N. Irland Eutrophic lake –
Pseudanabaena sp. CYA 435 2000 L. Victoria Uganda Eutrophic lake n.d.
Pseudanabaena sp. CYA 452 2000 Sandebukta SE. Norway Marine fjord n.d.
Pseudanabaena limnetica CYA 80 1976 L. Windermere England Mesotrophic lake T
Pseudanabaena limnetica CYA 276/6 1990 L. Ma¨laren E. Sweden Eutrophic lake n.d.
Symploca sp. CYA 316 1993 Lier, Buskerud SE. Norway Greenhouse soil –
Tychonema bornetii CYA 114/1 1983 River Gla˚ma SE. Norway Lotic biotope –
Tychonema bourrellyi CYA 33/1 1976 L. Mjøsa SE. Norway Mesotrophic lake T
B. Natural cyanobacteria populations from Norwegian inland waters collected during bloom conditions
Dominant species Natural sample Isolated Geographical location Biotope Mouse
toxicitya
Anabaena lemmermannii NWS 43 1992 L. Storavatn W. Norway Oligotrophic lake T
Anabaena lemmermannii NWS 44 1991 L. Storavatn W. Norway Oligotrophic lake N
Aphanizomenon cf. flos-aquae NWS 46 1998 L. Akersvatn SE. Norway Eutrophic lake T
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Primary hepatocytes were isolated from male Wistar rats
(80–150 g) by in vitro collagenase perfusion as previously
described [29, 33]. The experimental conditions were as
described in [17].
Scoring of apoptotic and necrotic cell death was by
microscopic (Axiovert 35 M, Zeiss) evaluation of surface
and nuclear morphology [17, 32, 41]. Each extract was
tested in triplicate at dilutions from a starting point
corresponding to 4 mg original dryweight biomass/ml
(4 mg/ml), and the LC50 (concentration needed to induce
50% cell death) determined (Table 2A, B). The extract
apoptogenicity was classified as high (LC50 \ 2 mg/ml),
intermediate (LC50: 2–4 mg/ml), low (LC50 [ 4 mg/ml;
25–49% death at 4 mg/ml), or as absent (\25% cell
death at 4 mg/ml). The potency of extracts from various
cyanobacterial orders and genera was compared by two-
way ANOVA, and least significance difference post hoc
tests with the SPSS software (Chicago, IL, USA).
Assay of protein serine/threonine
phosphatase 2A (PP2A) activity
PP2A was purified from rabbit muscle following the
previously described protocol [8]. Protein phosphatase
activity was measured by the release of radiolabeled
phosphate from [32P]-labeled phosphohistones as previ-
ously described [13]. In brief, 0.1 ml 50 mM Hepes
containing 1 mM EDTA, 0.3 mM EGTA, 0.5 mg/ml
BSA, 1 mM DTT, 1.25 mM MnCl2 was added either
cyanobacterial extract, MC-LR or vehicle together with
PP2A (8 nM). [32P]-histone (500 nM) was then added and
samples were left to incubate for 10 min at 30C before
stopping the reaction by addition of TCA to 7%. The
supernatant was added 0.15 ml 1 N H2SO4 containing
1 mM K2HPO4 and 0.2 ml 6% ammonium heptamolyb-
date in 1.4 N H2SO4. After 5 min of incubation, 0.6 ml of
isobutanol was added and samples were vortexed and
centrifuged at 1,100 9 g for 2 min. The isobutanol frac-
tions were collected and measured for content of [32P] by
liquid scintillation.
Purification of apoptosis-inducing compounds:
extraction, solid phase extraction (SPE), and reversed
phase high performance liquid chromatography
(HPLC)
Biomass (300 mg dryweight) was added to 25 ml water
(4C) and homogenized 6 9 30 s pulses (PolytronTyp
PT10/35, Kinematica, Switzerland). The homogenate was
incubated 2 h on ice in the dark before centrifugation
(40,000 9 g for 15 min) and washing with 12.5 ml of water.
The strong anion exchange SPE cartridge Sep-
PakAccellTMPlus QMA; 360 mg; Waters Corporation,
Milford, USA) was conditioned with 5.5 ml of methanol,
equilibrated with 5.5 ml of water, loaded with 1 ml of
water extract (corresponding to 6 mg original dryweight
biomass), and washed with 2.5 ml water. The load and
wash eluates were pooled.
Analytes in the non-retained fractions from the anion-
exchange SPE of the cyanobacterial strains CYA 225, CYA
399, CYA 94, or CYA 80 were separated on a reversed phase
chromatography column with nonpolar endcapping
(KromasilKR100-5-C18; 250 9 4.6 mm) coupled to a
Merck-Hitachi LaChrom HPLC system (VWR, West
Chester, USA) with a L-7455 diode array detector. The flow
rate was 0.8 ml/min and a 6-min run in isocratic mode with
94/6 (v/v %) water/acetonitrile was followed by a 24-min
linear gradient to 100% acetonitrile. Analytes in selected
HPLC fractions were further separated isocratically with
water as solvent on a reversed phase column with polar
endcapping (Aquasil C18; 150 9 3 mm) at a flow rate of
0.5 ml/min.
Mass spectrometry (MS)
Mass spectrometry was performed on a Quadrupole
Time-of-Flight (Q-ToF) Ultima Global Mass spectrome-
ter (Micromass, Manchester, UK) equipped with a
nanoflow z-spray source. Compounds in 0.5% formic acid
were infused into the mass spectrometer at a flow rate of
1–2 ll/min. MS spectra were acquired in positive ion
Table 1 continued
B. Natural cyanobacteria populations from Norwegian inland waters collected during bloom conditions
Dominant species Natural sample Isolated Geographical location Biotope Mouse
toxicitya
Microcystis aeruginosa NWS 48 1988 L. Frøylandsvatn W. Norway Eutrophic lake H
Phormidium cf. formosum NWS 45 1990 Dammenbekken, Larvik Norway Brook H
Planktothrix agardhii NWS 49 1991 L. Kalvsjøtjern Mid. Norway Eutrophic lake H
Planktothrix agardhii NWS 51 1980 L. Helgetjern SE. Norway Eutrophic/mixotrophic –
a Code mouse bioassay: H hepatotoxic, T toxicity, N neurotoxic, – not toxic, n.d. not determined
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Table 2 Potency of cyanobacterial extracts to induce cell death in myelogenic leukemia cells and T-lymphoma cells
A. Cyanobacterial strains from the NIVA Culture Collection of Algae
Species NIVA strain Myelogenic leukemia cells (IPC-81)a T-lymphoma cells (jurkat)a
A extract B extract C extract A extract B extract C extract
Order: Chroococcales
Chroococcus sp. CYA 330 – – – – – 2.8 ± 0.04
Cyanobium sp. CYA 230 – – 2.8 ± 0.17 [4 [4 1.9 ± 0.06
Cyanosarcina sp. CYA 386 – – – – – –
Cyanothece sp. CYA 304 – – – [4 [4 [4
Cyanothece aeruginosa CYA 258/2 – – – – – –
Merismopedia punctata CYA 16 [4 – – 4.0 ± 0.21 [4 –
Microcystis aeruginosa CYA 57 2.4 ± 0.11 – – – 1.6 ± 0.49 2.3 ± 0.41
Microcystis aeruginosa CYA 143 2.6 ± 0.11 – – – – [4
Microcystis aeruginosa CYA 160/1 – – – – [4 [4
Microcystis aeruginosa CYA 228/1 0.34 ± 0.00 – – – 2.5 ± 0.10 2.8 ± 0.11
Microcystis aeruginosa CYA 475 [4 – – [4 1.39 ± 0.15 1.27 ± 0.11
Microcystis aeruginosa CYA 476 [4 – 2.83 ± 0.22 2.50 ± 0.12 [4 [4
Microcystis aeruginosa CYA 477 2.46 ± 0.16 – – 2.05 ± 0.25 2.34 ± 0.38 [4
Microcystis aeruginosa CYA 478 2.60 ± 0.12 – [4 [4 – 2.16 ± 0.13
Microcystis botrys CYA 264 0.49 ± 0.05 [4 – 3.8 ± 0.18 – –
Microcystis cf. novacekii CYA 431 – – – – [4 –
Microcystis cf. wesenbergii CYA 172/5 0.73 ± 0.03 – – 0.32 ± 0.00 – 2.4 ± 0.52
Microcystis ichthyoblabe CYA 279 0.37 ± 0.00 – 2.5 ± 0.11 0.23 ± 0.02 [4 1.8 ± 0.07
Microcystis viridis CYA 122/2 0.71 ± 0.03 2.5 ± 0.12 – [4 – [4
Synechococcus sp. CYA 379 – – – – – [4
Synechococcus sp. CYA 388 3.0 ± 0.21 – – – 2.4 ± 0.15 2.2 ± 0.03
Synechococcus elongatus CYA 187 2.4 ± 0.22 – – – – –
Synechococcus nidulans CYA 20 – – – – [4 2.6 ± 0.05
Order: Nostocales
Anabaena circinalis CYA 82 2.4 ± 0.16 [4 – [4 – [4
Anabaena flos-aquae CYA 269/6 0.24 ± 0.01 [4 – 0.36 ± 0.00 2.1 ± 0.43 3.2 ± 0.59
Anabaena lemmermannii CYA 83/1 [4 – – – – –
Anabaena lemmermannii CYA 281/1 0.52 ± 0.03 – – 0.89 ± 0.16 – 2.6 ± 0.17
Anabaena lemmermannii CYA 298 0.66 ± 0.01 – – 1.0 ± 0.00 2.2 ± 0.05 –
Anabaena spiroides CYA 358 – – – – – –
Anabaena subcylindrica CYA 323 2.3 ± 0.37 – 2.5 ± 0.14 [4 – 2.2 ± 0.08
Anabaenopsis arnoldii CYA 135/2 0.67 ± 0.01 – – 2.2 ± 0.03 [4 –
Aphanizomenon gracile CYA 338 0.92 ± 0.17 [4 – [4 – [4
Aphanizomenon cf. klebahnii CYA 372 1.7 ± 0.28 – – – – [4
Cylindrospermopsis raciborskii CYA 225 0.59 ± 0.12 – 4.1 ± 0.12 2.5 ± 0.11 – 2.5 ± 0.13
Cylindrospermopsis raciborskii CYA 399 0.93 ± 0.05 2.5 ± 0.11 [4 2.0 ± 0.12 3.3 ± 0.02 2.4 ± 0.15
Cylindrospermum sp. CYA 245 2.4 ± 0.19 – [4 – – 4.1 ± 0.61
Dichothrix sp. CYA 518 – – – – – –
Nodularia cf. harveyana CYA 227 [4 – – – – –
Nostoc sp. CYA 124 [4 – – [4 – 2.5 ± 0.13
Nostoc sp. CYA 195 – – – – – [4
Nostoc sp. CYA 295 1.5 ± 0.04 – – 2.5 ± 0.11 [4 2.4 ± 0.15
Nostoc sp. CYA 308 – – – – – –
Nostoc sp. CYA 309 – – – – – –
Nostoc sp. CYA 512 – – – – – –
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Table 2 continued
A. Cyanobacterial strains from the NIVA Culture Collection of Algae
Species NIVA strain Myelogenic leukemia cells (IPC-81)a T-lymphoma cells (jurkat)a
A extract B extract C extract A extract B extract C extract
Nostoc sp. CYA 520 – – – [4 – –
Scytonema sp. CYA 345 – – – – – [4
Order: Oscillatoriales
Arthrospira sp. CYA 447 1.0 ± 0.03 – – 2.5 ± 0.11 – –
Leptolyngbya foveolarum CYA 54 2.8 ± 0.11 2.5 ± 0.11 – – – [4
Limnothrix redekei CYA 106 2.3 ± 0.12 2.5 ± 0.11 – – 3.1 ± 0.04 [4
Lyngbya cf. major CYA 173 – – 1.7 ± 0.08 – – 2.2 ± 0.09
Oscillatoria curviceps CYA 149 2.2 ± 0.13 – – – – [4
Phormidium breve CYA 76 3.0 ± 0.08 – – – – –
Phormidium sp. CYA 181 [4 – – – – –
Phormidium sp. CYA 184 – – – – – –
Phormidium sp. CYA 203 2.1 ± 0.12 – – – [4 2.5 ± 0.14
Phormidium sp. CYA 210 – – – [4 – –
Phormidium sp. CYA 315 – – – – – 3.4 ± 0.58
Phormidium sp. CYA 448 – – – [4 – –
Phormidium sp. CYA 454 – – – – – –
Phormidium cf. formosum CYA 110 2.0 ± 0.07 – – 2.5 ± 0.13 2.4 ± 0.15 –
Phormidium cf. subfuscum CYA177 – – – – – [4
Phormidium formosum CYA 92 1.1 ± 0.13 – – 2.5 ± 0.12 2.5 ± 0.14 2.4 ± 0.14
Planktothrix agardhii CYA 21 [4 – – [4 – [4
Planktothrix agardhii CYA 29 1.9 ± 0.02 – – – – 3.8 ± 0.74
Planktothrix agardhii CYA 116 [4 – – 2.5 ± 0.10 – –
Planktothrix agardhii CYA 126 2.8 ± 0.17 – – – – –
Planktothrix agardhii CYA 127 1.8 ± 0.07 – 4.1 ± 0.49 2.5 ± 0.10 – 2.7 ± 0.45
Planktothrix agardhii CYA 11 2.4 ± 0.05 – – [4 – –
Planktothrix rubescens CYA 406 [4 – – 2.3 ± 0.10 – –
Planktothrix rubescens CYA 98 2.1 ± 0.17 – – 3.0 ± 0.16 – –
Planktothrix rubescens CYA 97/3 3.5 ± 0.26 – – – – 3.2 ± 0.46
Planktothrix rubescens CYA 407 – – – [4 – [4
Prochlorothrix sp. CYA 8/90 2.3 ± 0.11 – – 2.5 ± 0.10 2.5 ± 0.14 –
Pseudanabaena sp. CYA 93 2.6 ± 0.12 [4 – – 2.9 ± 0.30 [4
Pseudanabaena sp. CYA 94 0.85 ± 0.14 – – – 2.3 ± 0.16 2.1 ± 0.17
Pseudanabaena sp. CYA 167 1.9 ± 0.15 2.5 ± 0.10 – 3.9 ± 0.29 [4 –
Pseudanabaena sp. CYA 435 [4 – – – – –
Pseudanabaena sp. CYA 452 2.8 ± 0.33 – – – – –
Pseudanabaena limnetica CYA 80 0.91 ± 0.12 – – – 2.4 ± 0.18 1.8 ± 0.13
Pseudanabaena limnetica CYA 276/6 2.4 ± 0.29 – – – [4 3.1 ± 0.41
Symploca sp. CYA 316 3.1 ± 0.10 – – – – –
Tychonema bornetii CYA 114/1 2.2 ± 0.18 [4 – – 3.5 ± 0.11 [4
Tychonema bourrellyi CYA 33/1 0.52 ± 0.03 [4 – 2.1 ± 0.03 2.5 ± 0.12 2.5 ± 0.13
B. Natural cyanobacteria populations from Norwegian inland waters collected during bloom conditions
Dominant species Natural sample Myelogenic leukemia cells (IPC-81)a T-lymphoma cells (jurkat)a
A extract B extract C extract A extract B extract C extract
Anabaena lemmermannii NWS 43 – [4 – – – 2.7 ± 0.53
Anabaena lemmermannii NWS 44 – 2.5 ± 0.13 – – [4 4.0 ± 0.60
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electrospray mode with a source temperature at 80C and
a capillary voltage of 3 kV. MS/MS analysis was with
collision energy of 20–40 V, but otherwise had similar
parameters.
Results and discussion
Apoptosis-inducing activity is frequent
in cyanobacteria and is independent of their
geographical origin
The cyanobacterial strains studied represented 27 genera
from the orders Chroococcales, Nostocales, and Oscilla-
toriales harvested from various biotopes located in areas
spanning polar, via temperate to tropical geographical
zones (Table 1A). Seven natural populations from Nor-
wegian freshwater blooms (Table 1B) were also studied.
To assess the apoptogenic activity in the cyanobacteria,
extracts of decreasing polarity were tested against jurkat
T-cell lymphoma and IPC-81 rat promyelogenic leukemia
cells. The jurkat T-cells are widely used to screen for
immunosuppressive agents [5, 14, 21, 34], whereas the
IPC-81 cells originate from the BNML rat model, which is
used for studying human AML and is known to be a reli-
able predictor of the potential of anti-leukemic drugs
(reviewed by [28]). Unlike normal cells of the myeloid
lineage the IPC-81 cells can be grown in conventional
medium, have very little spontaneous apoptosis [16, 25],
and are sensitive to commonly used anti-leukemic drugs
[15]. These cells were therefore used to assess the presence
of compounds with potential to be developed as drug
candidates for acute myelogenic leukemia. Both cell lines
were exposed for 18 h to aqueous (A), 70% methanol (B),
or dichloromethane/methanol (C) extracts of the cyano-
bacterial strains/populations. All but 18 of the 90 cyano-
bacterial samples showed apoptogenic activity towards the
T-cell lymphoma (Table 2). Nine of them induced apop-
tosis with high potency, and 41 with intermediate potency
(Table 2). We detected apoptogenic activity against AML
cells in all but 23 of the 90 cyanobacteria samples tested.
Twenty-two of them induced apoptosis with high potency,
and 32 with intermediate potency (Table 2).
We reasoned that the variety of genera, geographical
zone of origin, and biotope would reveal any correlation
between these parameters and the expression of apoptosis-
inducing activity in vitro. Much of the past research has
been into identification of bioactive cyanobacterial com-
pounds from tropical and sub-tropical environments. We
found no correlation between the apoptogenic activity and
the geographical location where the cyanobacteria had
been sampled (Tables 1, 2). However, we noted that there
was a correlation between cyanobacterial genera and the
amount of apoptogenic activity; the seven strains with
the most potent activity against T cells were all from the
genera Microcystis (4) or Anabaena (3). In contrast, these
genera accounted for only two of the 18 non-apoptogenic
strains (Table 2). The genera Anabaena and Microcystis
had also more anti-leukemic activity than Nostoc, Pho-
rmidium, Planktothrix, and Pseudanabaena (p \ 0.05).
In conclusion, the apoptosis-inducing activity appears to
be abundant in cyanobacteria, in particular of the genera
Microcystis or Anabaena, and is independent of geo-
graphical localization.
The apoptosis-inducing activity did not correlate
with the outcome of the mouse toxicity assay
The present cyanobacterial culture collection has been
created mainly to chart potentially toxic blooms and 47
of the selected strains and all the natural populations had
been tested in the mouse bioassay just after their isola-
tion. Of the tested strains, 24 were negative (no toxicity
observed 48 h after injection) and 30 were positive
Table 2 continued
B. Natural cyanobacteria populations from Norwegian inland waters collected during bloom conditions
Dominant species Natural sample Myelogenic leukemia cells (IPC-81)a T-lymphoma cells (jurkat)a
A extract B extract C extract A extract B extract C extract
Aphanizomenon cf. flos-aquae NWS 46 – 2.5 ± 0.13 – – – 3.1 ± 0.11
Microcystis aeruginosa NWS 48 2.0 ± 0.16 2.4 ± 0.11 – – [4 2.4 ± 0.12
Phormidium cf. formosum NWS 45 3.2 ± 0.25 [4 – [4 – [4
Planktothrix agardhii NWS 49 [4 – – – 4.0 ± 0.28 [4
Planktothrix agardhii NWS 51 2.4 ± 0.13 – – – 2.7 ± 0.04 [4
a Cells were incubated with various concentrations of cyanobacterial extracts (A aqueous, B 70% methanol, C methanol:dichloromethane) for
18 h and scored for cell death. Values are concentration (mg original dryweight biomass/ml) of extract required to induce 50% death
(mean ± SEM, n = 3). [4 signifies 25–50% cell death at 4 mg dw/ml, and – signifies \25% cell death at 4 mg dw/ml
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(56%). Of the positive samples, two induced signs of
neurotoxicity, 12 caused liver damage, and 16 exhibited
toxicity that could not be described as neurotoxic or
hepatotoxic (Table 1). The outcome of the mouse bio-
assay was similar between Chroococcales (14 positive,
12 negative) and Oscillatoriales (16 positive, 12
negative).
By comparing the content of apoptogens against T-cell
lymphoma and AML-cells and with the outcome of the
mouse bioassay we expected to reveal if toxin-producing
cyanobacteria were more or less likely to produce other
cell death-inducing compounds. No overall correlation
was observed between the outcome of the mouse bioassay
and content of apoptogenic activity against either cell line
(Tables 1, 2). The lacking predictive value of the mouse
bioassay is illustrated by comparing the nine extracts with
the strongest anti-T-cell lymphoma activity with the 18
non-apoptogenic extracts. Of the isolates in the first
group, three of the six tested in the mouse assay were
positive, while five of the seven isolates tested in the
second group were positive (Tables 1, 2). The same was
observed regarding the anti-AML activity. Among the 22
samples with high apoptogenic activity, 16 had been
tested by mouse bioassay, and of these, nine were positive,
while of the 23 without apoptogenic activity, 11 had been
tested in mouse bioassay and six of these were positive
(Tables 1, 2).
Still, we considered whether microcystin or similarly
acting protein phosphatase inhibitors could be responsible
for some of the anti-AML activity in the aqueous extracts,
since these toxins target major protein phosphatases that
are abundant in all eukaryotic cells. The hepatocytes are
primary targets due to their efficient microcystin uptake
[11, 26], but other cells can also be targeted at higher
concentration of microcystin [2], and microinjected micr-
ocystin induces apoptosis within a few minutes in all
mammalian cells tested [12]. We found that the LC50 for
microcystin-LR was 200 lM for the T-cell lymphoma and
150 lM for the AML cells and we have previously shown
that microcystins have a 20-fold higher apoptosis-inducing
activity towards hepatocytes than towards leukemia cells,
even if the leukemia cells were incubated with toxin for
18 h compared to the 1-h incubation of hepatocytes [17].
Twelve of the extracts with the highest anti-AML activity
were therefore assayed for content of microcystin-like
activity by the PP2A assay and some were also analyzed by
HPLC/MS (Table 3). The anti-AML activity did not cor-
relate with the microcystin content, which, as expected,
correlated closely with hepatotoxicity in the mouse bioas-
say and the induction of apoptosis in primary hepatocytes
(Table 3). The lower-than-expected activity of Microcystis
CYA 264 towards hepatocytes could be explained by the
content of a novel nostocyclopeptide inhibitor of micro-
cystin-induced hepatocyte apoptosis [20]. Furthermore, the
extract with the highest PP2A inhibitory content would
maximally contribute 13 lM microcystin to the AML cells,
and the type of apoptotic cell death observed (not shown)
differed from the one induced by protein phosphatase
inhibitors, which typically induce strongly polarized bleb-
bing in various cell types [12].
We conclude that the apoptogenic activity against T-cell
lymphoma and/or AML-cells could not be ascribed to
known phosphatase inhibitors and that the mouse bioassay
has little ability to predict the presence of AML and T-cell
Table 3 Content of phosphatase inhibitor, toxicity to mice and apoptosis induction in hepatocytes, and AML cells in cyanobacterial extracts








Microcystis aeruginosa CYA 228/1 930 ? H ???? ????
Microcystis botrys CYA 264 1300 ? n.d. ?? ????
Microcystis cf. wesenberghii CYA 172/5 3.5 - n.d. - ????
Microcystis ichthyoblabe CYA 279 \0.1 - – - ????
Microcystis viridis CYA 122/2 4.0 - n.d - ????
Anabaena flos-aquae CYA 269/6 270 ? H ???? ????
Anabaena lemmermannii CYA 281/1 \0.1 n.d. – - ????
Cylindrospermopsis raciborskii CYA 225 \0.1 n.d. T - ????
Cylindrospermopsis raciborskii CYA 399 \0.1 n.d. T - ????
Pseudanabaena sp. CYA 94 0.3 n.d. – - ????
Pseudanabaena limnetica CYA 80 \0.1 n.d. T - ????
Tychonema bourrellyi CYA 33/1 3.6 n.d. T - ????
Water extracts from 12 cyanobacterial isolates were assayed for content of PP2A inhibitory activity and expressed as MC-LR equivalents.
Toxicity to mice and the presence of microcystin was determined in some strains by HPLC and MS. Induction of apoptosis in AML cells and
primary hepatocytes by the 12 water extracts was also investigated. The scores signify: -,\10% apoptosis; ?, 10–25% apoptosis; ??, 25–50%
apoptosis; ???, 50–75% apoptosis; ????, 75–100% apoptosis
J Ind Microbiol Biotechnol (2011) 38:489–501 497
123
apoptogens. This is not unexpected if the apoptogens are
targeted against the immune system or the myeloid lineage
of the hematopoetic system, since life-threatening symp-
toms from the elimination or paralysis of these cells will
not be apparent during the short period of the acute mouse
bioassay. A negative response in the mouse bioassay pre-
dicts a lack of acutely acting toxins, and this might there-
fore be a positive trait in the search for therapeutic lead
compounds.
Cyanobacterial apoptogen diversity resulted
from differences between strains and the presence
of more than one activity in the same strain
Several of the cyanobacteria contained more than one
apoptogenic compound, since activity was detected in
both the aqueous (A) and the organic (C) extract, whereas
no activity was detected in the intermediate methanol (B)
extract (Table 2). In addition, A and C extracts often
produced apoptosis with different phenotypes (not
shown).
Apoptogens against AML cells were about as prevalent
as apoptogens against T-lymphoma cells. However, apop-
tosis-inducing activity towards AML cells was almost
completely confined to the aqueous (A) extracts, whereas
the apoptosis-inducing activity towards T-lymphoma cells
were generally found in the organic extract (Table 2).
Interestingly, we found that several strains contained both
activities. For instance, the Planktothrix strains CYA 29
and 97/3 contained an apoptogen specific towards AML
cells in the aqueous (A) extract and another apoptogen
specific towards T-cell lymphoma cells in the organic (C)
extract. In addition, two strains, Microcystis CYA 228/1
and Anabaena CYA 269/6, were proven to contain hepa-
totoxic microcystin in addition to apoptogens specific
towards T-cell lymphoma and/or AML-cells (Tables 2, 3).
Based on the difference in polarity of the A extract and
C extract, we conclude that the apoptosis-inducing activity
against T-cell lymphoma and AML-cells often resided in
different molecules.
The biosynthetic production of apoptogenic compounds
are preserved in cyanobacteria even after long-term
culturing
A potential problem in bioprospecting is the loss of bio-
synthetic capability for the substances of interest upon
culturing of the producing organism. We noted apopto-
genic activity in strains maintained in culture for several
years (Tables 1, 2). For instance, Phormidium CYA 76,
isolated in 1956, exhibited apoptosis-inducing activity and
Microcystis CYA 264, isolated in 1990, produced sub-
stantial amounts of microcystin. When we compared the
apoptogenicity of old and recent cultures, we found no
indications that the recently collected strains contained
more apoptogens than the formerly collected. This suggests
that the cyanobacteria maintain their original biosynthetic
capability after isolation and culturing, and underlines the
importance of culture collections.
To further study the apoptogenic activity in some of the
highly potent anti-AML extracts (Table 3), we performed
bio-guided isolation of the water extract. After extraction
and anion-exchange solid-phase extraction the apoptosis-
inducing activity was highly recovered (data not shown) in
four strains collected at different time-points and locations
(CYA225, CYA399, CYA94, CYA80). These four strains
had similar HPLC profiles, as shown for CYA94 in Fig. 1a,
as well as toxin profiles (not shown). The anti-AML frac-
tion in the beginning of the chromatogram (Fig. 1a) was
further separated and the apoptosis-inducing activity found
to reside in one peak (Fig. 1b) with a UV-spectrum
exhibiting a kmax at 199 nm (Fig. 1c). This highly polar
compound was common for both the Cylindrospermopsis
strains (CYA 225 and CYA 399) and the Pseudanabaena
strains (CYA 80 and CYA 94), as determined by reten-
tion time, absorbance spectra, and MS analysis. The
molecular mass of the compound was 159.3 Da
(Fig. 1d). This mass differs from that of known bloom-
associated cyanobacterial toxins. Upon MS/MS, two
fragments (m/z: 143 and m/z: 126) were created, corre-
sponding to the loss of one and two masses of 17 Da
(Fig. 1e). The fragmentation pattern was similar to that
seen in some amines [36].
This demonstrates that cultured cyanobacteria, even
after long-term culturing under axenic conditions, consti-
tute a renewable source for toxins and interesting apopto-
genic compounds.
Concluding remarks
This study demonstrates that cyanobacteria kept in culture
not only give toxicological information but also represent a
renewable source for other bioactive compounds.
There was no correlation between mouse toxicity and
induction of apoptosis neither in T-cell lymphoma nor in
AML-cells, which indicates that cyanobacteria produce a
diversity of still uncharacterized bioactive compounds. The
present findings indicate that cyanobacteria in addition to
production of specific toxins like microcystin, were able to
produce high levels of other cell death-inducing com-
pounds, irrespective if collected from blooms or not.
The biosynthetic capability of cyanobacteria [10] offers an
opportunity for finding novel useful compounds, as illustrated
by several cyanobacterial anti-cancer agents currently under
development [30, 35]. The negative mouse bioassay for many
498 J Ind Microbiol Biotechnol (2011) 38:489–501
123
strains with high content of activity against T-cell lymphoma
or AML-cells (Tables 1, 2) is in this context an advantage
since it suggests that the compounds have only limited acute
toxicity in the intact organism. In fact, 23 cyanobacterial
strains and one natural population that were non-toxic to mice
contained apoptogens. This suggests that culture collections
of cyanobacteria without toxicity against mammals constitute
a valuable source for bioactive compounds with pharmaceu-
tical potential.
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Fig. 1 Analysis of apoptosis-inducing compounds by HPLC and
mass spectrometry. a Analytes in anion-exchange SPE fraction of
CYA 94 were separated by reversed phase HPLC. Fractions were
collected and tested for the ability to induce cell death in AML cells.
A major death-inducing activity eluted in fraction 4 (3–4 min) and
was termed 94-4 (boxed). b The 94-4 fraction was further fractionated
by polar endcapped reversed C18 phase HPLC chromatography. The
bioactivity (dotted line) eluted with a peak with retention time of
1.91 min. c–e The peak (94-4-1.91) was analyzed by UV spectros-
copy (c), and mass spectrometry (MS) (d) and MS/MS (e)
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